Pieris Pharmaceuticals, Inc. announced that Darlene Deptula-Hicks has submitted her resignation, effective February 7, 2017, to pursue other interests. While the company conducts an executive search for a permanent successor, Lance Thibault of Danforth Advisors, is assuming the role of Acting Chief Financial Officer. Ms. Darlene Deptula-Hicks joined Pieris Pharmaceuticals as Senior Vice President and Chief Financial Officer in September 2015.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.36 USD | +2.07% | +6.26% | -28.85% |
05-15 | Pieris Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | Pieris Pharmaceuticals Shares Fall After 1-for-80 Reverse Stock Split Announcement | MT |
1st Jan change | Capi. | |
---|---|---|
-28.85% | 13.4M | |
+13.69% | 118B | |
+12.96% | 106B | |
-2.74% | 24.28B | |
+0.82% | 21.96B | |
-9.37% | 18.16B | |
-42.12% | 16.37B | |
-17.74% | 15.56B | |
+4.94% | 13.63B | |
+31.64% | 12.27B |
- Stock Market
- Equities
- PIRS Stock
- News Pieris Pharmaceuticals, Inc.
- Pieris Pharmaceuticals, Inc. Announces Management Changes